International Journal of Online and Biomedical Engineering, published by the Int Federation Engineering Education Societies (IFEES), serves as an essential platform for the dissemination of innovative research in the fields of biomedical engineering and online engineering education. Established in 2005, this Open Access journal promotes wider accessibility and collaboration among researchers, educators, and practitioners worldwide. With an impressive impact factor and recognition in the Scopus rankings, where it ranks in the 69th percentile for General Engineering and 43rd percentile for Biomedical Engineering, the journal is positioned as a critical resource in advancing interdisciplinary knowledge and fostering technological advancements. The scope of the journal includes a diverse range of topics, enhancing its relevance in both academia and industry. As it converges from 2019 to 2024, the journal continues to embrace cutting-edge research that bridges online learning and biomedical engineering, encouraging submissions that reflect the dynamic interplay of these vital domains. Researchers, professionals, and students are invited to contribute and benefit from the growing repository of knowledge that this journal offers.

Biocybernetics and Biomedical Engineering, published by ELSEVIER in the Netherlands, is a prestigious journal that stands at the forefront of the intersecting fields of biomedical engineering and artificial intelligence. With an impressive Impact Factor that places it in the Q1 category for Biomedical Engineering, this journal not only ranks 17th out of 303 in Scopus but also boasts a remarkable percentile ranking of 94th, highlighting its influence and relevance within the scientific community. Since its inception in 2008, Biocybernetics and Biomedical Engineering has aimed to publish cutting-edge research that integrates principles of cybernetics with technological advancements in health care, thereby fostering innovations that improve patient outcomes. Dedicated to advancing knowledge in biomedical technology, the journal serves as a vital resource for researchers, professionals, and students seeking to explore the latest developments and methodologies in the field.

The Journal of Mechanics in Medicine and Biology, published by World Scientific Publishing Co Pte Ltd, serves as a critical platform for interdisciplinary research at the intersection of engineering and biomedical sciences. With an ISSN of 0219-5194 and E-ISSN of 1793-6810, this esteemed journal has been dedicated to exploring the mechanical principles that govern biological systems since its inception in 2008. Based in Singapore, it addresses a diverse range of topics, from biomaterials to biomechanics, contributing valuable insights into the field’s evolving landscape. Although currently positioned in Q4 of Biomedical Engineering according to the 2023 category quartiles, it is poised for growth and increased visibility within the scientific community, fostering innovation and collaboration among researchers, professionals, and students alike. The journal emphasizes the importance of cutting-edge research and its practical implications, making it a vital resource for those striving to enhance the future of medical technologies and biological understanding.

Computer Methods in Biomechanics and Biomedical Engineering - Imaging and Visualization is a prominent academic journal published by Taylor & Francis Ltd, dedicated to the intersection of computational methods and biomedical engineering. With an ISSN of 2168-1163 and an E-ISSN of 2168-1171, the journal has become a crucial resource for researchers and professionals exploring innovative imaging and visualization techniques in healthcare. Covering a broad spectrum of topics, it aims to facilitate the advancement of knowledge in areas such as biomechanics, computational mechanics, and medical imaging. Holding a strong position in various Scopus rankings, including Q2 in Computational Mechanics, it offers valuable insights that foster interdisciplinary collaboration. Although it is not an open-access journal, researchers can access its rich repository of knowledge, which is instrumental in shaping future advancements in biomedical applications. The journal’s commitment to quality and relevance ensures that it remains an authoritative source for emerging trends and methodologies within the field, serving as a vital tool for academia and industry practitioners alike.

Current Opinion in Biomedical Engineering is a renowned journal published by Elsevier, focusing on the cutting-edge developments and critical assessments in the fields of biomedical engineering and related disciplines. With an ISSN of 2468-4511, it provides a valuable platform for researchers and professionals to disseminate their insights and discoveries in areas such as bioengineering, biomaterials, and medicine. Its impressive impact factor positions it in the Q2 category for several fields, including Bioengineering and Biomedical Engineering, highlighting its influence and relevance in ongoing scientific dialogues. The journal’s unique format of opinion pieces and reviews encourages innovative thinking and fosters collaboration among experts. As an essential resource for those engaged in the life sciences and engineering, Current Opinion in Biomedical Engineering serves to stimulate discussion, promote knowledge exchange, and drive advancements in biomedical applications. Set in the Netherlands at Radarweg 29, 1043 NX Amsterdam, the journal is accessible through various academic platforms, enabling a global readership to engage with the latest scholarly work in this dynamic field.

Biomedical Signal Processing and Control is a premier academic journal published by ELSEVIER SCI LTD that stands at the forefront of the rapidly evolving fields of biomedical engineering, health informatics, and signal processing. With an impressive impact factor reflecting its scholarly influence and high standards of research, this journal has been recognized in the Q1 quartile category across multiple disciplines as of 2023. Specifically, it holds esteemed positions within Biomedical Engineering, Health Informatics, and Signal Processing, where it ranks in the top tier of its field on Scopus: #19/131, #21/138, and #47/303 respectively. Published continually from 2006 to 2024, the journal serves as a critical platform for researchers, healthcare professionals, and students, fostering innovation in signal processing techniques and their applications in biomedical systems. Access to cutting-edge research and methodologies makes it an indispensable resource for advancing knowledge and practice within these interdisciplinary domains.

The International Journal of Biomedical Engineering and Technology, published by INDERSCIENCE ENTERPRISES LTD, serves as a pivotal platform for the dissemination of innovative research in the field of biomedical engineering. This journal, with ISSN 1752-6418 and E-ISSN 1752-6426, has been a valuable resource since its inception in 2007, boasting a converged publication timeline extending to 2024. Based in the United Kingdom, the journal aims to bridge the gap between engineering and biomedical sciences, facilitating interdisciplinary collaboration. As reflected in its 2023 Scopus ranking in the Q4 quartile of Biomedical Engineering, the journal remains accessible for researchers at various stages of their careers, contributing to its significance in promoting advancements in healthcare technologies. While currently not an open-access publication, the journal remains dedicated to enriching the biomedical engineering community by presenting novel research that addresses critical challenges, ultimately aiming to improve patient outcomes and drive innovation in medical devices and therapies.

MEDICAL ENGINEERING & PHYSICS, published by Elsevier Science Ltd, is an esteemed journal in the fields of Biomedical Engineering and Biophysics. With an ISSN of 1350-4533 and an E-ISSN of 1873-4030, it has established itself as a significant resource from its inception in 1994, continuing to deliver pivotal research up to 2024. This journal, categorized in the Q3 quartile for both Biomedical Engineering and Biophysics, holds a respectable position in Scopus rankings, boasting its relevance in the upper echelons of academic inquiry, particularly ranking #75/152 in Biophysics and #158/303 in Biomedical Engineering. Authors and researchers in these dynamic fields will find the journal’s rigorous peer-review process and commitment to publishing high-quality original research invaluable for advancing their work. Although the journal is not open access, it continues to attract submissions that push the boundaries of innovation and application in medical technologies, making it an essential resource for anyone dedicated to the integration of engineering principles with medical sciences.

Biomedical Engineering Online, published by BMC, is an esteemed open-access journal in the United Kingdom that has been advancing the field of biomedical engineering since its inception in 2002. With a commitment to disseminating high-quality research, the journal encompasses a broad scope, including innovative studies in biomaterials, imaging technologies, and medical applications. Recognized within the Q2 quartile for various categories such as Biomaterials and Biomedical Engineering, it ranks favorably among its peers: Rank #58 out of 333 in Radiology, and Rank #15 out of 63 in Radiological and Ultrasound Technology in the Scopus database. These rankings, coupled with an open-access model, ensure that critical advancements in medical technology are accessible to researchers, health professionals, and students globally. As it continues through its converged years from 2002 to 2024, Biomedical Engineering Online remains an invaluable resource for anyone involved in the cutting-edge intersection of engineering and medicine.

Bioengineering & Translational Medicine, published by WILEY, positions itself at the forefront of innovation in the fields of biomedical engineering, biotechnology, and pharmaceutical science. With an impressive impact factor reflected through its top-tier Q1 rankings in multiple categories, the journal serves as a critical platform for disseminating cutting-edge research and stimulating discourse among professionals and scholars since its establishment as an open-access journal in 2016. Key to its mission is facilitating the translation of bioengineering research into tangible medical applications, thereby enhancing healthcare outcomes. With its comprehensive scope, it attracts a diverse readership, including researchers, industry leaders, and students eager to engage with the latest developments in translational medicine. The journal operates under robust access options, ensuring that research is freely available for maximum reach and impact, fostering collaboration and innovation across disciplines worldwide.